FDA PMA FDA Class 3 Approved 🇺🇸 United States

Heart-Valve, Non-Allograft Tissue

PMA: P170006 · Supplement: S025 · Decision Jan 31, 2024
Classifications
1
FEI Numbers
19
Registration Numbers
19

Basic Information

Device Name
Heart-Valve, Non-Allograft Tissue
Trade Name
Avalus Ultra Bioprosthesis
PMA Number
P170006
Supplement Number
S025
Device Class
FDA Class 3
Product Code
LWR
Generic Name
heart-valve, non-allograft tissue
Medical Specialty
Unknown
Advisory Committee
Cardiovascular
Decision
Approved
Decision Code
APPR
Decision Date
January 31, 2024
Date Received
September 1, 2023
Supplement Type
Normal 180 Day Track
Supplement Reason
Change Design/Components/Specifications/Material
Expedited Review
N

Advisory Committee Statement

Approval for design modifications to the Avalus Bioprosthesis device including the addition of a radiopaque marker and changes to the stent base design and sewing ring. The device, as modified, will be marketed under the trade name Avalus Ultra Bioprosthesis.

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
LWR Heart-Valve, Non-Allograft Tissue